OPKO Health (OPK) Reports Second Rayaldee Phase 3 Met Primary Endponts
Tweet Send to a Friend
OPKO Health, Inc. (NYSE: OPK), announced successful top-line results from the second and final pivotal phase 3 trial of Rayaldee ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
